Intraocular Infiltration

Koju Kamoi Department of Ophthalmology and Visual Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan

Search for other papers by Koju Kamoi in
Current site
Google Scholar
PubMed
Close
and
Kyoko Ohno-Matsui Department of Ophthalmology and Visual Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan

Search for other papers by Kyoko Ohno-Matsui in
Current site
Google Scholar
PubMed
Close

A 58-year-old man presented with general malaise and showed positive results for human T-cell leukemia virus type 1 (HTLV-1) infection. As blood tests revealed abnormal leukocytes and flower cells, smoldering-type adult T-cell leukemia/lymphoma (ATL) was diagnosed. After 7 years, the condition changed to acute-type ATL. Blood tests identified an increase in CD4 from 995 cells/µL to 1,256 cells/µL and monoclonal integration of HTLV-1 provirus into tumor cells. Treatment was started with chemotherapy and allogeneic bone marrow transplantation. During follow-up, he was referred to the ophthalmology department after experiencing sudden visual loss in the right eye.

Slit-lamp examination revealed cellular infiltration in the anterior chamber and vitreous humor. Fundus examination showed yellowish-white infiltrative foci associated with protrusions in the retina. Optical coherence tomography revealed massive solid infiltrative foci below the retinal pigment epithelium (Figure 1). As differential diagnoses for co-infections of the eye, our recent nationwide survey revealed cytomegalovirus (CMV) as a major cause of opportunistic infection in the eye of ATL patients, followed by herpesvirus and toxoplasma.1 In addition, co-infections of the eye in immunocompetent patients are not frequently confirmed using serologic diagnostic methods.2 Multiplex polymerase chain reaction (PCR) and broad-range PCR of a sample of aqueous humor, therefore, ruled out viral (human simplex virus-1 and 2, varicella zoster virus, Epstein–Barr virus, CMV, and human herpesvirus 6–8), toxoplasma, tuberculosis, syphilis, and bacterial and fungal infections, ruling out opportunistic infection and allowing the diagnosis of intraocular leukemic cell infiltration.3 Elevated lesions on the retina improved after two vitreous injections of 400 μg/0.1 mL of methotrexate and subsided with five sessions of 2-Gy radiotherapy. Corresponding to this combination therapy, retinal lesions gradually resolved within 6 months (Figure 2).

Figure 1.
Figure 1.

Yellowish-white infiltrative foci associated with protrusions in the retina (upper figure). Optical coherence tomography reveals massive solid infiltrative foci below the retinal pigment epithelium (lower figure). White line represents scan line.

Citation: The American Journal of Tropical Medicine and Hygiene 102, 1; 10.4269/ajtmh.19-0539

Figure 2.
Figure 2.

Infiltration is reduced 6 months after vitreous injection of methotrexate concomitant with radiotherapy.

Citation: The American Journal of Tropical Medicine and Hygiene 102, 1; 10.4269/ajtmh.19-0539

Globally, HTLV-1 infection is now the focus of attention, since the discovery that more than 40% of adults from Aboriginal communities in central Australia are infected with HTLV-1.4 This infection causes ATL and also visual impairment by ATL-related ocular manifestations.5 As HTLV-1–associated ATL is a neoplasia characterized by massive invasion of leukemic cells into various organs, physicians should keep in mind that intraocular infiltration is the most frequent manifestation observed among HTLV-1–associated ATL patients.1

REFERENCES

  • 1.↑

    Kamoi K, Okayama A, Izumo S, Hamaguchi I, Uchimaru K, Tojo A, Ohno-Matsui K, 2018. Adult T-cell leukemia/lymphoma-related ocular manifestations: analysis of the first large-scale nationwide survey. Front Microbiol 9: 3240.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.↑

    de-la-Torre A et al. 2019. Coinfections and differential diagnosis in immunocompetent patients with uveitis of infectious origin. BMC Infect Dis 19: 91.

  • 3.↑

    Mochizuki M, Sugita S, Kamoi K, Takase H, 2017. A new era of uveitis: impact of polymerase chain reaction in intraocular inflammatory diseases. Jpn J Ophthalmol 61: 1–20.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.↑

    Martin F, Tagaya Y, Gallo R, 2018. Time to eradicate HTLV-1: an open letter to WHO. Lancet 391: 1893–1894.

  • 5.↑

    Kamoi K, Mochizuki M, 2012. HTLV infection and the eye. Curr Opin Ophthalmol 23: 557–561.

Author Notes

Address correspondence to Koju Kamoi, Department of Ophthalmology and Visual Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. E-mail: koju.oph@tmd.ac.jp

Authors’ addresses: Koju Kamoi and Kyoko Ohno-Matsui, Department of Ophthalmology and Visual Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan, E-mails: koju.oph@tmd.ac.jp and k.ohno.oph@tmd.ac.jp.

  • Figure 1.

    Yellowish-white infiltrative foci associated with protrusions in the retina (upper figure). Optical coherence tomography reveals massive solid infiltrative foci below the retinal pigment epithelium (lower figure). White line represents scan line.

  • Figure 2.

    Infiltration is reduced 6 months after vitreous injection of methotrexate concomitant with radiotherapy.

  • 1.

    Kamoi K, Okayama A, Izumo S, Hamaguchi I, Uchimaru K, Tojo A, Ohno-Matsui K, 2018. Adult T-cell leukemia/lymphoma-related ocular manifestations: analysis of the first large-scale nationwide survey. Front Microbiol 9: 3240.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    de-la-Torre A et al. 2019. Coinfections and differential diagnosis in immunocompetent patients with uveitis of infectious origin. BMC Infect Dis 19: 91.

  • 3.

    Mochizuki M, Sugita S, Kamoi K, Takase H, 2017. A new era of uveitis: impact of polymerase chain reaction in intraocular inflammatory diseases. Jpn J Ophthalmol 61: 1–20.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Martin F, Tagaya Y, Gallo R, 2018. Time to eradicate HTLV-1: an open letter to WHO. Lancet 391: 1893–1894.

  • 5.

    Kamoi K, Mochizuki M, 2012. HTLV infection and the eye. Curr Opin Ophthalmol 23: 557–561.

Past two years Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1200 738 44
PDF Downloads 365 106 14
 
 
 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save